Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
Condition(s):Testicular Neoplasms; SeminomaLast Updated:July 6, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Testicular Neoplasms; SeminomaLast Updated:July 6, 2023Recruiting
Condition(s):Neuroendocrine Tumors; Neuroendocrine CarcinomaLast Updated:November 3, 2021Recruiting
Condition(s):Merkel Cell CarcinomaLast Updated:October 17, 2023Not yet recruiting
Condition(s):Extensive Disease; First-Line; Small Cell Lung CancerLast Updated:January 26, 2016Terminated
Condition(s):Extensive-stage Small-cell Lung CancerLast Updated:March 13, 2023Not yet recruiting
Condition(s):Carcinoma, Small Cell LungLast Updated:March 20, 2024Active, not recruiting
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:April 24, 2012Completed
Condition(s):Small Cell Lung CarcinomaLast Updated:February 25, 2013Terminated
Condition(s):Extensive Stage Lung Small Cell Carcinoma; Recurrent Lung Small Cell CarcinomaLast Updated:March 8, 2024Active, not recruiting
Condition(s):Extensive-stage Small Cell Lung CancerLast Updated:June 14, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.